GRAIL Partners with Epic to Expand Access to Galleri Multi-Cancer Early Detection Test

Integration Will Allow Clinicians to Seamlessly Order the Galleri Test Within Epic's Electronic Health Record Platform

Apr. 8, 2026 at 6:05am

Got story updates? Submit your updates here. ›

A ghostly, translucent X-ray photograph revealing the internal structure of a medical diagnostic device, glowing with a faint, ethereal light against a dark background, conceptually representing the advanced technology behind early cancer detection.The integration of the Galleri multi-cancer early detection test into Epic's electronic health record platform aims to make this innovative screening technology more accessible to healthcare providers and patients.Menlo Park Today

GRAIL, a healthcare company focused on early cancer detection, has announced a collaboration with Epic to integrate the Galleri multi-cancer early detection test into Epic's electronic health record (EHR) platform. This integration will enable approximately 450 health systems to access Galleri test results directly within their existing patient portals and clinical workflows, reducing administrative burden and improving the provider and patient experience.

Why it matters

The Galleri test is designed to detect more than 50 types of cancer before symptoms appear, when the disease is often more treatable. By integrating Galleri into the widely used Epic EHR system, GRAIL aims to expand access to this innovative cancer screening technology and support earlier cancer detection, which can lead to better health outcomes.

The details

The integration through Epic Aura will allow healthcare providers to order the Galleri test directly within their native EHR environment, receive results, and manage patient follow-up seamlessly. This streamlined process is expected to eliminate administrative barriers and encourage broader adoption of the Galleri test across health systems.

  • Implementation planning began in the first quarter of 2026.
  • Broad availability of the Galleri test integration is expected by the end of 2026.

The players

GRAIL, Inc.

A healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on using next-generation sequencing, population-scale clinical studies, and machine learning to develop multi-cancer early detection tests.

Epic

A leading electronic health record (EHR) platform used by many of the largest and most advanced health systems in the United States.

Galleri

A multi-cancer early detection test that can detect more than 50 types of cancer before symptoms appear, with the goal of enabling earlier treatment and improved outcomes.

Josh Ofman, MD, MSHS

President at GRAIL.

Alan Hutchison

Vice President at Epic.

Got photos? Submit your photos here. ›

What they’re saying

“With a scalable integration through Epic, we are reducing operational barriers and making it easier for healthcare providers to incorporate the Galleri test into routine care, with the ultimate goal of supporting early cancer detection before symptoms appear, when outcomes may be better.”

— Josh Ofman, MD, MSHS, President at GRAIL

“Aura helps healthcare organizations collaborate by removing administrative barriers. With GRAIL joining the Epic community, together with healthcare organizations, we can advance early detection and ultimately improve cancer survival rates.”

— Alan Hutchison, Vice President at Epic

“Integrating Galleri directly into Epic enables us to incorporate multi-cancer early detection into routine clinical care in a seamless way for both providers and patients. By embedding Galleri within our existing EHR infrastructure, we reduce administrative burden, support appropriate patient identification, and streamline ordering within established workflows.”

— Philip Oravetz, M.D., Chief Population Health Officer at Ochsner Health

What’s next

GRAIL will work closely with Epic and AWS, as well as interested health systems, community healthcare providers, and retail health clinics, to support workflow alignment, training, and deployment of the Galleri test integration.

The takeaway

By integrating the Galleri multi-cancer early detection test into the widely used Epic EHR platform, GRAIL aims to expand access to this innovative technology and support earlier cancer detection, which can lead to improved health outcomes for patients.